HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Peter J. Horneffer Vincent L. Gott Timothy J. Gardner Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Horneffer, P. J. Articles by Gardner, T. J. Search for Related Content PubMed PubMed Citation Articles by Horneffer, P. J. Articles by Gardner, T. J.

Ann Thorac Surg 1986;42:139-142
© 1986 The Society of Thoracic Surgeons

---

Articles

Retrograde Coronary Sinus Perfusion Prevents Infarct Extension during Intraoperative Global Ischemic Arrest

Division of Cardiac Surgery, the Johns Hopkins Hospital, Baltimore, MD

^* Address reprint requests to Dr. Gardner, Division of Cardiac Surgery, Blalock 618, The Johns Hopkins Hospital, Baltimore, MD 21205

To determine whether continuous infusion of cardioplegia retrograde through the coronary sinus could improve the salvage of infarcting myocardium, 54 pigs were utilized in a region at risk model. All hearts underwent 30 minutes of reversible coronary artery occlusion, and were divided into six groups. Group 1 served as controls and underwent two hours of coronary reflow without global ischemic arrest. The remaining five groups were subjected to 45 minutes of cardioplegia-induced hypothermic arrest followed by two hours of normothermic reflow. Group 2 had a single infusion of crystalloid cardioplegia, and Group 3 received an oxygenated perfluorocarbon cardioplegic solution initially and again after 20 minutes of ischemia. After initial cardiac arrest with crystalloid cardioplegia, all hearts in Groups 4, 5, and 6 underwent a continuous infusion of a cardioplegic solution retrograde through the coronary sinus. Group 4 received a nonoxygenated crystalloid cardioplegic solution, Group 5 received an oxygenated crystalloid cardioplegic solution, and Group 6 received an oxygenated perfluorocarbon cardioplegic solution.

With results expressed as the percent of infarcted myocardium within the region at risk, Group 2 hearts, which received only antegrade cardioplegia, had a mean infarct size of 44.8 ± 6.3%, a 2.2-fold increase over controls (p < 0.05). While antegrade delivery of oxygenated perfluorocarbon cardioplegia (Group 3) and coronary sinus perfusion with nonoxygenated crystalloid cardioplegia (Group 4) limited infarct size to 33.6 ± 4.7% and 35.3 ± 5.4%, respectively, only oxygenated cardioplegia delivered retrograde through the coronary sinus (Groups 5 and 6) completely prevented infarct extension during global ischemic arrest. Infarct sizes were 26.6 ± 4.6% in Group 5 and 24.2 ± 4.0% in Group 6 (p < 0.05 versus Group 2). These data suggest that optimal salvage of ischemic myocardium might best be achieved by the use of retrograde coronary sinus perfusion of oxygenated cardioplegia during surgical revascularization.

This article has been cited by other articles:

				L. R. Sajja, A. Farooqi, R. B. Yarlagadda, S. S. Mastan, R. B. Pothineni, L. R. Sajja, A. Farooqi, R. B. Yarlagadda, S. S. Mastan, and R. B. Pothineni Retrograde Coronary Sinus Perfusion for Severe Left Main Stenosis Asian Cardiovasc Thorac Ann, September 1, 2000; 8(3): 290 - 291. [Abstract] [Full Text] [PDF]

				A. H. Huang, I. O. Sofola, B. L. Bufkin, R. J. Mellitt, and R. A. Guyton Coronary sinus pressure and arterial venting do not affect retrograde cardioplegia distribution Ann. Thorac. Surg., November 1, 1994; 58(5): 1499 - 1504. [Abstract] [PDF]

				K. V. Arom and R. W. Emery Coronary sinus cardioplegia: Clinical trial with only retrograde approach Ann. Thorac. Surg., June 1, 1992; 53(6): 965 - 971. [Abstract] [PDF]

				P. S. Greene, D. E. Cameron, E. M. Griffiths, J. M. DiNatale, and T. J. Gardner Does hypothermic fibrillatory arrest improve myocardial protection during emergency revascularization? Ann. Thorac. Surg., July 1, 1989; 48(1): 38 - 42. [Abstract] [PDF]

				K. S. Naunheim, A. C. Fiore, D. C. Arango, D. G. Pennington, H. B. Barner, L. R. McBride, H. H. Harris, V. L. Willman, and G. C. Kaiser Coronary artery bypass grafting for unstable angina pectoris: Risk analysis Ann. Thorac. Surg., April 1, 1989; 47(4): 569 - 574. [Abstract] [PDF]

				J. T. Diehl, E. J. Eichhorn, M. A. Konstam, D. D. Payne, A. R. Dresdale, R. M. Bojar, H. Rastegar, J. J. Stetz, D. N. Salem, R. J. Connolly, et al. Efficacy of Retrograde Coronary Sinus Cardioplegia in Patients Undergoing Myocardial Revascularization: A Prospective Randomized Trial Ann. Thorac. Surg., June 1, 1988; 45(6): 595 - 602. [Abstract] [PDF]